Nitric oxide release: Part II. Therapeutic applications

被引:819
作者
Carpenter, Alexis W. [1 ]
Schoenfisch, Mark H. [1 ]
机构
[1] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
SOL-GEL MICROARRAYS; DONOR DRUGS; BACTERIAL ADHESION; S-NITROSOTHIOL; CANCER-THERAPY; IN-VIVO; ANTIBACTERIAL PROPERTIES; NEOINTIMAL HYPERPLASIA; SILICA NANOPARTICLES; SYNTHASE INHIBITORS;
D O I
10.1039/c2cs15273h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A wide range of nitric oxide (NO)-releasing materials has emerged as potential therapeutics that exploit NO's vast biological roles. Macromolecular NO-releasing scaffolds are particularly promising due to their ability to store and deliver larger NO payloads in a more controlled and effective manner compared to low molecular weight NO donors. While a variety of scaffolds (e. g., particles, dendrimers, and polymers/films) have been cleverly designed, the ultimate clinical utility of most NO-releasing macromolecules remains unrealized. Although not wholly predictive of clinical success, in vitro and in vivo investigations have enabled a preliminary evaluation of the therapeutic potential of such materials. In this tutorial review, we review the application of macromolecular NO therapies for cardiovascular disease, cancer, bacterial infections, and wound healing.
引用
收藏
页码:3742 / 3752
页数:11
相关论文
共 98 条
[31]   What Part of NO Don't You Understand? Some Answers to the Cardinal Questions in Nitric Oxide Biology [J].
Hill, Bradford G. ;
Dranka, Brian P. ;
Bailey, Shannon M. ;
Lancaster, Jack R., Jr. ;
Darley-Usmar, Victor M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (26) :19699-19704
[32]   Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy [J].
Hirst, David ;
Robson, Tracy .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (04) :411-420
[33]   Inhibition of nitric oxide synthase as a potential therapeutic target [J].
Hobbs, AJ ;
Higgs, A ;
Moncada, S .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :191-220
[34]   Nitric Oxide-Loaded Echogenic Liposomes for Nitric Oxide Delivery and Inhibition of Intimal Hyperplasia [J].
Huang, Shao-Ling ;
Kee, Patrick H. ;
Kim, Hyunggun ;
Moody, Melanie R. ;
Chrzanowski, Stephen M. ;
MacDonald, Robert C. ;
McPherson, David D. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (07) :652-659
[35]  
Ignarro L.J., 2000, NITRIC OXIDE BIOL PA
[36]   Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide - An overview [J].
Ignarro, LJ ;
Napoli, C ;
Loscalzo, J .
CIRCULATION RESEARCH, 2002, 90 (01) :21-28
[37]   ENDOTHELIUM-DERIVED RELAXING FACTOR PRODUCED AND RELEASED FROM ARTERY AND VEIN IS NITRIC-OXIDE [J].
IGNARRO, LJ ;
BUGA, GM ;
WOOD, KS ;
BYRNS, RE ;
CHAUDHURI, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :9265-9269
[38]   S-nitrosylation of human variant albumin liprizzi (R410C) confers potent antibacterial and cytoprotective properties [J].
Ishima, Yu ;
Sawa, Tomohiro ;
Kragh-Hansen, Ulrich ;
Miyamoto, Yoichi ;
Matsushita, Sadaharu ;
Akaike, Takaaki ;
Otagiri, Masaki .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (03) :969-977
[39]   Biomaterials based on chitin and chitosan in wound dressing applications [J].
Jayakumar, R. ;
Prabaharan, M. ;
Kumar, P. T. Sudheesh ;
Nair, S. V. ;
Tamura, H. .
BIOTECHNOLOGY ADVANCES, 2011, 29 (03) :322-337
[40]   Reduced ischemia/reperfusion injury via glutathione-initiated nitric oxide-releasing dendrimers [J].
Johnson, Timothy A. ;
Stasko, Nathan A. ;
Matthews, Jessica L. ;
Cascio, Wayne E. ;
Holmuhamedov, Ekhson L. ;
Johnson, C. Bryce ;
Schoenfisch, Mark H. .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2010, 22 (01) :30-36